Clinical trial
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
NCT00270634 · Aurinia Pharmaceuticals Inc., Industry · Completed
Key facts
| NCT number | NCT00270634 |
|---|---|
| Title | Study of ISA247 (Voclosporin) in De Novo Renal Transplantation |
| Official title | A Phase IIb, Randomized, Multicenter, Open-Label, Concentration Controlled, Safety Study of ISA247 (Voclosporin) and Tacrolimus (Prograf®) in De Novo Renal Transplant Patients |
| Acronym | PROMISE |
| Lead sponsor | Aurinia Pharmaceuticals Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | Voclosporin, tacrolimus |
| Enrollment | 334 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Dec 28, 2005 |
| Last update posted | Feb 12, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: